Whilst preparing this report, the ABPI Pharmaceutical Ophthalmology Initiative (POPI) has assessed the wealth of research and material developed over the last few years and supplemented and updated this by interviewing a range of key stakeholders in the eye care community.
Based on this research, we have come up with a number of recommendations intended to chart a realistic way forward at a time of great change and opportunity. The recommendations are structured around three key themes: commissioning, awareness and prevention and the delivery of treatments and services.
All views expressed are those of the ABPI POPI group.
Last modified: 20 September 2023
Last reviewed: 20 September 2023